Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NMTcNP-8 by NeoMatrix Therapeutics for Burns: Likelihood of Approval
NMTcNP-8 is under clinical development by NeoMatrix Therapeutics and currently in Phase I for Burns. According to GlobalData, Phase I...